Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Colorcon

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: irinotecan hydrochloride

See Plans and Pricing

« Back to Dashboard

IRINOTECAN

CASRN: 97682-44-5

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Merck
Johnson and Johnson
AstraZeneca
Medtronic